Brinker Capital’s Novartis NVS Stock Holding History

Brinker Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$10.1M	Buy	115,004 +3,429	+3%	+$296K	0.32%	61
2020 Q1	$9.22M	Buy	111,575 +8,831	+9%	+$788K	0.37%	54
2019 Q4	$9.75M	Buy	102,744 +6,758	+7%	+$606K	0.3%	72
2019 Q3	$8.37M	Sell	95,986 -4,055	-4%	-$364K	0.29%	73
2019 Q2	$9.16M	Sell	100,041 -6,267	-6%	-$530K	0.33%	57
2019 Q1	$9.19M	Sell	106,308 -738	-0.7%	-$59.2K	0.35%	56
2018 Q4	$8.26M	Sell	107,046 -233	-0.2%	-$18.1K	0.37%	54
2018 Q3	$8.31M	Buy	107,279 +5,538	+5%	+$409K	0.3%	64
2018 Q2	$6.92M	Buy	101,741 +5,459	+6%	+$377K	0.27%	74
2018 Q1	$7.01M	Buy	96,282 +5,787	+6%	+$441K	0.27%	70
2017 Q4	$6.83M	Buy	90,495 +11,487	+15%	+$867K	0.27%	74
2017 Q3	$6.1M	Sell	79,008 -21,971	-22%	-$1.66M	0.25%	84
2017 Q2	$7.58M	Buy	100,979 +29,958	+42%	+$2.12M	0.35%	55
2017 Q1	$4.75M	Buy	71,021 +19,580	+38%	+$1.3M	0.22%	100
2016 Q4	$3.47M	Buy	51,441 +39,931	+347%	+$2.59M	0.19%	114
2016 Q3	$821K	Buy	11,510 +2,956	+35%	+$215K	0.08%	101
2016 Q2	$639K	Buy	8,554 +1,931	+29%	+$133K	0.06%	135
2016 Q1	$437K	Buy	+6,623	New	+$451K	0.04%	211

Other funds holding NVS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Brinker Capital's NVS Position: Q2 2020 in Review

Brinker Capital increased its Novartis (NVS) stake by 3.1% in Q2 2020, buying an estimated $296K and bringing the position to 115,004 shares worth $10.1M. The position accounts for 0.32% of the portfolio, ranked #61.

Brinker Capital first reported a position in NVS in Q1 2016 and has held it in 18 quarters since. 1,129 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

Brinker Capital held 115,004 shares of Novartis worth $10.1M as of Q2 2020.
Brinker Capital bought 3,429 Novartis shares in Q2 2020, an estimated $296K.
Novartis made up 0.32% of Brinker Capital's portfolio in Q2 2020, its #61 holding.
Brinker Capital first reported a position in Novartis in Q1 2016 and has held it in 18 quarters since.
1,129 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.